% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Lohmann:860442,
      author       = {Lohmann, Philipp and Werner, Jan-Michael and Shah, N. and
                      Fink, Gereon Rudolf and Langen, Karl-Josef and Galldiks,
                      Norbert},
      title        = {{C}ombined {A}mino {A}cid {P}ositron {E}mission
                      {T}omography and {A}dvanced {M}agnetic {R}esonance {I}maging
                      in {G}lioma {P}atients},
      journal      = {Cancers},
      volume       = {11},
      number       = {2},
      issn         = {2072-6694},
      address      = {Basel},
      publisher    = {MDPI},
      reportid     = {FZJ-2019-01196},
      pages        = {153 -},
      year         = {2019},
      abstract     = {Imaging techniques such as positron emission tomography
                      (PET) and magnetic resonance imaging (MRI) provide valuable
                      information about brain tumor patients. Particularly amino
                      acid PET, advanced MRI techniques, and combinations thereof
                      are of great interest for the non-invasive assessment of
                      biological characteristics in patients with primary or
                      secondary brain cancer. A methodological innovation that
                      potentially advances research in patients with brain tumors
                      is the increasing availability of hybrid PET/MRI systems,
                      which enables the simultaneous acquisition of both imaging
                      modalities. Furthermore, the advent of ultra-high field MRI
                      scanners operating at magnetic field strengths of 7 T or
                      more will allow further development of metabolic MR imaging
                      at higher resolution. This review focuses on the combination
                      of amino acid PET with MR spectroscopic imaging, perfusion-
                      and diffusion-weighted imaging, as well as chemical exchange
                      saturation transfer in patients with high-grade gliomas,
                      especially glioblastomas},
      cin          = {INM-3 / INM-4 / INM-5 / INM-11},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406 /
                      I:(DE-Juel1)INM-5-20090406 / I:(DE-Juel1)INM-11-20170113},
      pnm          = {572 - (Dys-)function and Plasticity (POF3-572)},
      pid          = {G:(DE-HGF)POF3-572},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:30699942},
      UT           = {WOS:000460747200027},
      doi          = {10.3390/cancers11020153},
      url          = {https://juser.fz-juelich.de/record/860442},
}